concanavalin-a and Arterivirus-Infections

concanavalin-a has been researched along with Arterivirus-Infections* in 2 studies

Other Studies

2 other study(ies) available for concanavalin-a and Arterivirus-Infections

ArticleYear
Antibody production and blastogenic response in pigs experimentally infected with porcine reproductive and respiratory syndrome virus.
    Canadian journal of veterinary research = Revue canadienne de recherche veterinaire, 1996, Volume: 60, Issue:2

    Seven five-week piglets were infected intranasally with 10(5) TCID50 of porcine reproductive and respiratory syndrome (PRRS) virus strain IAF.exp91. All virus-exposed pigs developed fever, labored abdominal breathing, conjunctivitis, and lymph node enlargement within the first 96 h postexposure (PE), which continued to d 10 to 14 PE. Two pigs that were necropsied at d 7 and 10 PE had diffuse interstitial pneumonitis, cardiopathy and lymphadenopathy. All 5 remaining pigs produced serum IgM and IgG antibodies against PRRS virus by 7 or 14 days PE, as demonstrated by indirect immunofluorescence. This corresponded with the capability of isolating the virus from serum d 7 to d 49 or d 63 PE. Low serum neutralizing antibody titers were detected in 3 of the virus-exposed pigs by 35 days PE. A transient episode of diminished proliferative response of peripheral blood lymphocytes to mitogens phytohemagglutinin (PHA) and concanavalin A (Con A) was observed in the virus-exposed pigs at d 3 PE. However, in vitro spontaneous uptake of [3H]-thymidine was significantly increased in lymphocyte cultures of the same pigs at d 7 or d 14 PE. These results suggest polyclonal activation of peripheral blood lymphocytes.

    Topics: Animals; Antibodies, Viral; Antibody Formation; Arterivirus Infections; Concanavalin A; Fluorescent Antibody Technique, Indirect; In Vitro Techniques; Lymph Nodes; Lymphocyte Activation; Phytohemagglutinins; Reference Values; Swine; Swine Diseases; Time Factors

1996
Nitric oxide production by splenic macrophages is not responsible for T cell suppression during acute infection with lactate dehydrogenase-elevating virus.
    Journal of immunology (Baltimore, Md. : 1950), 1994, Jun-15, Volume: 152, Issue:12

    Cellular immune responses of mice are transiently suppressed during acute infection with lactate dehydrogenase-elevating virus (LDV). Immunosuppression of mice correlated with a greatly impaired in vitro proliferative response of the majority of the T cells to Con A or anti-CD3 Abs, which could not be reversed by the addition of rIL-2. We have examined whether the T cell suppression is caused by nitric oxide (NO) produced by activated macrophages, which are observed in acutely infected mice. Spleen macrophages from 3-day LDV-infected mice exhibited a 6- to 10-fold increased potential for producing NO, measured as nitrite or nitrite plus nitrate in the culture fluid, but produced significant amounts of NO in vitro only when incubated with IFN-gamma produced by Con A-stimulated T cells in the spleen cell population. Furthermore, we found that the concentrations of NO produced by macrophages in cultures of spleen cells from LDV-infected mice in the presence of IFN-gamma were insufficient to cause a reduction in the proliferative response of T cells in the spleen cell population. An excess of activated macrophages had to be added to achieve T cell suppression. NO inhibition of Con A-induced T cell proliferation exhibited a very sharp dose-response curve. In one experiment little suppression was observed at NO concentrations equivalent to 12 microM nitrite and below, whereas almost complete inhibition was observed at twice the NO concentration. We conclude that NO is not responsible for T cell suppression in LDV-infected mice.

    Topics: Animals; Arterivirus Infections; Concanavalin A; Immune Tolerance; Immunity, Cellular; In Vitro Techniques; Interferon-gamma; Interleukin-2; Lactate dehydrogenase-elevating virus; Lymphocyte Activation; Macrophage Activation; Macrophages; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Nitric Oxide; Spleen; T-Lymphocytes

1994